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Abstract
Introduction: Ketamine is a derivative of phencyclidine and is a dissociative anaesthetic. Its use as
a recreational drug is on the increase among young adults attending clubs and parties.
Case presentation: We describe the case of a 20-year-old man who presented with a 7-month
history of urinary frequency, nocturia, urgency, suprapubic discomfort during micturition and
episodes of severe haematuria shortly after commencing weekly recreational ketamine use.
Complementary examinations were negative except for a thickened bladder wall on ultrasound
examination and mild inflammatory changes on cystoscopy. So far only nine cases of ketamine-
associated ulcerative cystitis have been described.
Conclusion: We expect that in the future an increasing number of cases of cystitis caused by
ketamine use will be seen in young adults.
Introduction
Ketamine is a derivative of phencyclidine, a popular street
drug which is known as 'PCP' or 'angel dust'. Ketamine is
less potent and shorter acting compared with phencyclid-
ine and is used as a dissociative anaesthetic in humans [1].
Ketamine, known as 'Special K', is becoming more widely
used among young adults attending clubs and parties,
including raves [2]. It is labelled a 'club drug' by the
National Institute on Drug Abuse (NIDA) of the United
States. The effects of ketamine include profound changes
in consciousness and psychotomimetic symptoms, such
as out-of-body experiences [3]. It can also induce a state of
virtual helplessness and a pronounced lack of coordina-
tion [4]. Negative effects include increased heart and res-
piratory rates, nausea and vomiting, convulsions,
temporary paralysis and hallucinations [2]. So far only
one report has described the effect of ketamine on the uri-
nary system: nine patients were found to have developed
a ketamine-associated ulcerative cystitis [5]. We report an
additional case.
Case presentation
We describe the case of a 20-year-old man who presented
with a 7-month history of urinary frequency, nocturia,
urgency, suprapubic discomfort during micturition and
episodes of severe haematuria shortly after commencing
weekly recreational ketamine use. The patient occasion-
ally works as a disk jockey at 'hardstyle' and 'jump' parties.
His past medical history was significant for nose polyps
and asthma, for which he was treated with montelukast
(Singulair®) and fluticasone propionate in combination
with salmeterol (Seretide®). He had never travelled out-
side of Europe.
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After 2 months of symptoms he had been treated with
antibiotics for 5 days and anticholinergics for several
weeks without any improvement. Routine urine analysis
and urine cytology were negative and a urine culture was
sterile. An ultrasound examination revealed a thickened
bladder wall and a small bladder capacity but normal kid-
neys. Cystoscopy showed mild inflammatory changes,
although there was no visual blood in the urine. Bladder
biopsies were negative; however, they were not taken dur-
ing an episode of active cystitis. We advised the patient to
stop ketamine use.
Discussion
Ketamine-associated cystitis appears to be a new clinical
entity. So far only nine cases have been described, all of
which reported daily ketamine users who presented with
severe dysuria, frequency, urgency and severe haematuria
[5] (Table 1). Urine cultures were sterile in all patients.
Computed tomography revealed marked thickening of
the bladder wall, a small bladder capacity and perivesicu-
lar stranding, consistent with severe inflammation. At cys-
toscopy, the bladder walls of eight patients showed
multiple erythematous patches. In one patient mild squa-
mous metaplasia and reddened flat ulcerated patches
were noted on cystoscopy. Biopsies in four patients
revealed epithelial denudation and inflammation with a
mild eosinophilic infiltrate. All patients benefited from
cessation of ketamine use. In one case the addition of pen-
tosane polysulphate appeared to provide some sympto-
matic relief.
In our case cystoscopy showed only mild signs of inflam-
mation and biopsies were negative. However, our patient
used ketamine only on a weekly basis, whereas the
patients described in the literature were daily users. This
could explain the difference between our patient's cystos-
copy and biopsy findings with those of the nine cases
reported in the literature. Moreover, in our patient the
biopsies were not taken during an episode of active cysti-
tis. We suspect, however, that ketamine was the cause of
the patient's complaints, as the timing of the onset of
symptoms correlated strongly with the commencement of
ketamine use. In addition, the evidence shows our case to
be consistent in many ways with the nine other cases
described in the literature (Table 1).
The mechanism by which ketamine induces cystitis is not
clear. Ketamine and its metabolites norketamine and
hydroxynorketamine can be measured in high quantities
in the urine of patients using ketamine [6]. It is possible
that ketamine and its active metabolites cause significant
bladder irritation.
Conclusion
As ketamine is being used increasingly as a recreational
drug we expect ketamine-associated cystitis to become
more prevalent in young adults. Health care workers
should be aware of the problem and patients should be
informed about the possible side effects of ketamine. The
long-term sequelae of ketamine on the bladder remain
unknown.
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Table 1: Characteristics of 10 patients with ketamine-associated cystitis reported in the literature.
Our patient Patient 1 Patient 2 Patient 3 Patients 4–9
Age 20 years 28 years 25 years 17 years Unknown
Sex Man Man Woman Man Unknown
Ketamine use Weekly Daily Daily Daily Daily
Duration of 
symptoms
7 months 6 months 2 years Several months Unknown
Urine cultures Sterile Sterile Sterile Sterile Sterile
Bladder wall Thickened Thickened Thickened Thickened Thickened
Cystoscopy Mild inflammation Erythematous patches Mild squamous 
metaplasia, ulcerated 
patches
Erythematous patches Erythematous patches
Biopsy Negative Epithelial denudation, 
inflammation, 
eosinophilic infiltrate
Unknown Unknown In three patients, 
similar to patient 1
Antibiotic therapy Unsuccessful Unsuccessful Unknown Unknown Unknown
Benefited from 
cessation of 
ketamine
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